Pages that link to "Q36534797"

The following pages link to Effects of Saccharomyces boulardii on intestinal mucosa (Q36534797):

Displaying 36 items.

• Transduction pathways regulating the trophic effects of Saccharomyces boulardii in rat intestinal mucosa (Q28573133) (← links)
• Lactobacillus acidophilus stimulates the expression of SLC26A3 via a transcriptional mechanism (Q33727385) (← links)
• Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice (Q33830723) (← links)
• Modulation of intestinal inflammation by yeasts and cell wall extracts: strain dependence and unexpected anti-inflammatory role of glucan fractions (Q34357982) (← links)
• Probiotics in infectious diarrhoea in children: are they indicated? (Q34646254) (← links)
• Microorganisms linked to inflammatory bowel disease-associated dysbiosis differentially impact host physiology in gnotobiotic mice. (Q35719490) (← links)
• Cellular and molecular effects of yeast probiotics on cancer. (Q36113199) (← links)
• Effectiveness of Saccharomyces boulardii in a rat model of colitis (Q36429838) (← links)
• Probiotic agents in the treatment of irritable bowel syndrome (Q36953712) (← links)
• Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives (Q37182888) (← links)
• Protective Yeasts Control V. anguillarum Pathogenicity and Modulate the Innate Immune Response of Challenged Zebrafish (Danio rerio) Larvae. (Q37338635) (← links)
• Indications for the use of probiotics in gastrointestinal diseases (Q37969593) (← links)
• The role of probiotics and prebiotics in inducing gut immunity. (Q38174603) (← links)
• Microencapsulation of Saccharomyces cerevisiae and its evaluation to protect in simulated gastric conditions (Q38407029) (← links)
• Probiotic Saccharomyces cerevisiae strains as biotherapeutic tools: is there room for improvement? (Q38542708) (← links)
• Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice. (Q39056083) (← links)
• Oral administration of Saccharomyces boulardii alters duodenal morphology, enzymatic activity and cytokine production response in broiler chickens (Q42502726) (← links)
• Recent advances in Saccharomyces boulardii research (Q42871284) (← links)
• The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea (Q46207994) (← links)
• Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission (Q46515415) (← links)
• Saccharomyces boulardii ingestion increases the humoral response of a DNA vaccine against leptospirosis in mice (Q46675427) (← links)
• Saccharomyces boulardii CNCM I-745 Improves Intestinal Enzyme Function: A Trophic Effects Review. (Q49957312) (← links)
• Treatment with Saccharomyces boulardii reduces the inflammation and dysfunction of the gastrointestinal tract in 5-fluorouracil-induced intestinal mucositis in mice. (Q50479632) (← links)
• Anti-inflammatory effects ofSaccharomyces boulardiimediated by myeloid dendritic cells from patients with Crohn's disease and ulcerative colitis (Q52893090) (← links)
• Effect of abomasal carbohydrates and live yeast on measures of postruminal fermentation. (Q53198093) (← links)
• Raf: A key regulatory kinase for transduction of mitogenic and metabolic signals of the probiotic Saccharomyces boulardii (Q54584053) (← links)
• Saccharomyces boulardiidecreases inflammation and intestinal colonization byCandida albicansin a mouse model of chemically-induced colitis (Q56019290) (← links)
• Mechanism and therapeutic effects of Saccharomyces boulardii on experimental colitis in mice (Q58594084) (← links)
• The Quest for Novel Antimicrobial Compounds: Emerging Trends in Research, Development, and Technologies (Q63246529) (← links)
• Beneficial effects of CNCM I-745 on clinical disorders associated with intestinal barrier disruption (Q64242873) (← links)
• Sepsis: mechanisms of bacterial injury to the patient (Q64246126) (← links)
• Establishment of intestinal microbiota with focus on yeasts of unweaned and weaned piglets kept under different farm conditions (Q84095162) (← links)
• Effect of a single dose of Saccharomyces cerevisiae var. boulardii on the occurrence of porcine neonatal diarrhoea (Q85565648) (← links)
• Search and Selection of Probiotics That Improve Mucositis Symptoms in Oncologic Patients. A Systematic Review (Q90459802) (← links)
• Linking perturbations to temporal changes in diversity, stability, and compositions of neonatal calf gut microbiota: prediction of diarrhea (Q95661105) (← links)
• Overview of the Potential Role of Malassezia in Gut Health and Disease (Q96304697) (← links)